Stay updated on Elranatamab Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.
Latest updates to the Elranatamab Combo in Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2, indicating a minor metadata update that does not alter core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check19 days agoChange DetectedAdded three new study sites: Kantonsspital Winterthur (Winterthur, Switzerland), The First Affiliated Hospital of Soochow University (Suzhou, Jiangsu, China), and Southern Medical University Nanfang Hospital (Guangzhou, Guangdong, China). The total number of locations is now 76 and the recruitment status is Active, not recruiting.SummaryDifference0.8%
- Check34 days agoChange DetectedNew related topics/keywords were added to the page: 'Multiple myeloma' and 'MedlinePlus Genetics'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check48 days agoChange DetectedThe page now lists many new study locations and updated recruitment statuses, increasing the total locations to 73 and including new dates. This suggests broader site coverage and ongoing recruitment across more locations.SummaryDifference3%
- Check55 days agoChange DetectedRemoved a MedlinePlus Genetics topic on multiple myeloma, reducing genetics-related content on the page.SummaryDifference0.2%
- Check62 days agoChange DetectedVersion updated from v3.1.0 to v3.2.0 with an operational status notice and a new MedlinePlus Genetics topic on multiple myeloma.SummaryDifference3%
Stay in the know with updates to Elranatamab Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.